Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Feb 28, 2024

SELL
$112.47 - $130.98 $22,494 - $26,195
-200 Closed
0 $0
Q2 2022

Feb 28, 2024

BUY
$67.99 - $132.89 $10,198 - $19,933
150 Added 300.0%
200 $14.9 Million
Q1 2019

May 06, 2019

BUY
$28.07 - $38.18 $1,403 - $1,909
50 New
50 $6,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Acima Private Wealth, LLC Portfolio

Follow Acima Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acima Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acima Private Wealth, LLC with notifications on news.